510(k) · Cleared
ClearedOpart/Prodiga, Opart/Protenza, Opart/Paragon
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Toshiba America Mri, Inc. · LNH System, Nuclear Magnetic Resonance Imaging
Cleared on Jan 18, 2000 as substantially equivalent to K990260 (Toshiba America Mri, Inc., 1999) and 5 other predicates after an 89-day review. Its family tree reaches back 4 generations to 1990. 1 later device descends from it.
- Decided
- Jan 18, 2000
- Review
- 89 days
- Class
- Class II
- Product code
- LNH
- Recalls
- None
- Predicates
- 6
Its longest line of descent runs back 4 generations to K903768 (1990). 13 ancestors in all, the oldest K900889 (1990). 1 later device descends from it, 1 citing it directly.
- Root · 4 generations backK903768 Magnetic Resonance Device MRT 150AToshiba America Mri, Inc. · 1990
- 3 generations backK961092 VisartToshiba America Medical Systems, In.C · 1996 · Recalled
- 2 generations backK965068 Magnetic Resonanc Dvce Visart V 3.5 SoftwareToshiba America Medical Systems, In.C · 1997
- 1 generation backK983110 Flexart,Flexart/Hyper, Visart, Visart/HyperToshiba America Mri, Inc. · 1999
- This deviceK993574 Opart/Prodiga, Opart/Protenza, Opart/ParagonToshiba America Mri, Inc. · 2000
- Descendant · cites it directly · 0 of its ownK023207 Opart (Including Opart Ultra and Ultra Gradient Upgrade Kit)Toshiba America Medical Systems, In.C · 2002
Most influential descendants
Showing 1 of 1 · See all- K023207Opart (Including Opart Ultra and Ultra Gradient Upgrade Kit)Toshiba America Medical Systems, In.C · 2002 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −4 | K903768 | Magnetic Resonance Device MRT 150A | Toshiba America Mri, Inc. | 1990 | — |
| −3 | K961092 | Visart | Toshiba America Medical Systems, In.C | 1996 | 5 |
| −2 | K965068 | Magnetic Resonanc Dvce Visart V 3.5 Software | Toshiba America Medical Systems, In.C | 1997 | — |
| −1 | K983110 | Flexart,Flexart/Hyper, Visart, Visart/Hyper | Toshiba America Mri, Inc. | 1999 | — |
| 0 (this device) | K993574 | Opart/Prodiga, Opart/Protenza, Opart/Paragon | Toshiba America Mri, Inc. | 2000 | — |
| +1 | K023207 | Opart (Including Opart Ultra and Ultra Gradient Upgrade Kit) | Toshiba America Medical Systems, In.C | 2002 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1990 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2002 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LNH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LNH device
- #1 K213693 MAGNETOM Vida with syngo MR XA50Ascore 23.0 · 18 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (6)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K990260 | OPARTSummary page 1…additional features available in each subsequent version (see Comparison Table, Appendix B, for detailed description). A brief description follows: v3.0: Based on v2.5 (K990260) with MR Angio and FASE sequences removed v3.1: Based on v2.5 (K990260) v3.2: Based on v2.6 (K990260) v3.3: Based on v2.6 (K990… | 1999 |
| * | K983110 | Flexart,Flexart/Hyper, Visart, Visart/HyperSummary page 3…ftware (K981475). Version v3.3 adds Diffusion/Perfusion imaging to the indications for use statement and is substantially equivalent to v4.0 software for FLEXART/VISART (K983110). The Extremity Array coil is substantially equivalent to the currently cleared OPART™ Extremity coil (K962933). The Fluoro monit… | 1999 |
| * | K962933 | Opart MRT-600Summary page 3…stantially equivalent to v4.0 software for FLEXART/VISART (K983110). The Extremity Array coil is substantially equivalent to the currently cleared OPART™ Extremity coil (K962933). The Fluoro monitor and pointing device is substantially equivalent to the currently cleared OPART™ Fluoro monitor (K962933). Th… | 1996 |
| * | K962138 | Flexart V3.1 SoftwareSummary page 3…ared OPART™ Fluoro monitor (K962933). The Peripheral Pulse gating unit is substantially equivalent to the VISART/FLEXART Peripheral Pulse gating described in K983110 and K962138. The Motorized Bed is substantially equivalent to the ACCESS™ Compass Bed (K946244/A1) and the FLEXART Bed (K933018/S1). A.4 ==… | 1996 |
| * | K946244 | Access (TM) Compass BedSummary page 3…ally equivalent to the VISART/FLEXART Peripheral Pulse gating described in K983110 and K962138. The Motorized Bed is substantially equivalent to the ACCESS™ Compass Bed (K946244/A1) and the FLEXART Bed (K933018/S1). A.4 Public Health Secvice NEALY o ,./(C DEPARTMENT OF HEALTH & HUMAN SER… | 1995 |
| * | K933018 | MRT-50GPSummary page 3…XART Peripheral Pulse gating described in K983110 and K962138. The Motorized Bed is substantially equivalent to the ACCESS™ Compass Bed (K946244/A1) and the FLEXART Bed (K933018/S1). A.4 Public Health Secvice NEALY o ,./(C DEPARTMENT OF HEALTH & HUMAN SERVICES Q Food and Drug Administrat… | 1994 |
| † | K981475 | Opart (MRT-600) Versions 2 Software Upgrade | 1998 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K023207 | Opart (Including Opart Ultra and Ultra Gradient Upgrade Kit) | 2002 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 10 years and passes through 2 companies; a new generation was cleared every 1.6 years on median.
- 2 of the 13 ancestors have a recall of any class.
- Of its descendants, K023207 (Toshiba America Medical Systems, In.C, 2002) has gone furthest, with 0 descendants of its own.
- 1 other device also cites its predicate K990260.
How does its category compare?
All LNH devicesLNH System, Nuclear Magnetic Resonance Imaging: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · LNH
26in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LNH
122in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LNH
8in 2025
Class I (8 since 2007) Class II/III not classified
Adverse event reports per year · LNH
1,263in 2025
MAUDE reports naming product code LNH, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 12 | 35 | 25 | 114 |
| 2008 | 19 | 53 | 12 | 167 |
| 2009 | 17 | 70 | 7 | 194 |
| 2010 | 12 | 94 | 17 | 165 |
| 2011 | 16 | 81 | 11 | 182 |
| 2012 | 22 | 89 | 5 | 170 |
| 2013 | 19 | 108 | 2 | 107 |
| 2014 | 17 | 108 | 13 | 119 |
| 2015 | 19 | 140 | 12 (2) | 113 |
| 2016 | 20 | 108 | 1 | 135 |
| 2017 | 18 | 98 | 0 | 121 |
| 2018 | 29 | 128 | 71 | 158 |
| 2019 | 26 | 62 | 5 | 158 |
| 2020 | 32 | 121 | 4 | 98 |
| 2021 | 27 | 87 | 41 | 84 |
| 2022 | 30 | 74 | 13 | 138 |
| 2023 | 30 | 124 | 10 (1) | 159 |
| 2024 | 26 | 104 | 4 | 281 |
| 2025 | 26 | 122 | 8 (5) | 1,263 |
| 2026 | 24 | 126 | 43 | — |
What is it indicated for?
Imaging of:
- The Whole Body (including head, abdomen, pelvis, limbs and extremities, spine, neck, TMJ, heart, blood vessels). [Application terms include MRCP (MR Cholangiopancreatography), MR Urography, MR Myelography, MR Fluoroscopy, SAS (Surface Anatomy Scan), Dynamic Scan and Cine Imaging.]
- Fluid Visualization
- 2D/3D Imaging
Additional indications for v3.1, v3.2, & v3.3 (only)
- MR Angiography/MR Vascular Imaging
Additional indication for v3.2 & v3.3 (only)
- Water/Fat Imaging
Additional indication for v3.3 (only)
- Perfusion/Diffusion Imaging
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K993574 · printed Nov 4, 2026
Cite this page
510(k) Report. “K993574: Opart/Prodiga, Opart/Protenza, Opart/Paragon.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K993574
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026